Secondary endpoints will be determination of prevalence of medication nonadherence based on self-reported questionnaire (the Morisky medication adherence scale), determination of predictive factors of medication nonadherence in the population studied and to compare the prevalence of medication nonadherence based on anti factor Xa dosing to the Morisky medication adherence scale.